BLOCKStrain: Three Target Markets, One Breakthrough Platform
Ryan Allway
March 19th, 2019
Exclusive, News, Top News
The global cannabis industry is projected to reach nearly $150 billion by 2025, according to Grand View Research, as a growing number of governments legalize marijuana. While legalization has created an overnight multi-billion dollar market for investors, consumers, cultivators, and regulators have struggled to build regulations around such a rapidly growing industry, and that has created numerous challenges across the value chain.
BLOCKStrain Technology Corp. (TSX-V: DNAX) (OTC: BKKSF) has created the world’s first integrated blockchain platform that registers and tracks intellectual property for the cannabis industry. In doing so, the company solves many of the challenges facing consumers, retailers, cultivators, and regulators. Investors may want to keep a close eye on the company given its early traction in North America and broad appeal to multiple parts of the industry.
Consumers & Retailers
Cannabis consumers have very little information about how certain cannabis strains will affect their body. Even worse, microbial or chemical contamination can make some cannabis outright dangerous for human consumption. There’s no way for consumers to be truly confident in their purchases—they must usually trust the brand or dispensary. Similarly, dispensaries must trust cultivators when they purchase their inventory.
BLOCKStrain’s data and certification system gives consumers the information they need to make informed decisions about the products that they purchase. Using a QR code, consumers can track the path the product has taken to retail shelves, along with the cannabinoid and terpene profiles needed to make smart decisions. They can also be confident that the product is chemically-pure and free of pesticides and molds.
For retailers and distributors, BLOCKStrain helps protect reputations by ensuring that 100% of the product going to retail has passed through all of the correct testing and screening processes. The BLOCKStrain Seal is quickly being adopted as the single source of trust for consumers, and by stocking shelves with verified products, you can inspire confidence in customers and ensure that they keep returning again and again.
Cultivators & Licensed Producers
Cannabis is a complex plant with over 400 properties that differ between strains, depending on the seed, fiber, cannabinoid content, regional or cultivation environments, growth characteristics, flavor, or terpene profile. While patents can help protect strain-related intellectual property on a theoretical level, it can be difficult to license strains to other cultivators without the risk of them cloning the plant and selling it as their own.
BLOCKStrain’s platform enables cultivators to release their varieties into the public domain without fear of losing their ownership claim or rights to be paid for intellectual property. They can easily manage and share the history of a clone, as well as the data collected during its grow cycle. In addition, the technology eases the burden of collecting and reporting administrative data to conserve resources and ensure accuracy.
For example, the company recently signed a validation testing program agreement with Harvest One Cannabis Inc. (TSX-V: HVT) (OTCQX: HRVOF), a Canadian licensed producer of medical cannabis, to deploy its proprietary genome tracking software to collect and register its cannabis plant DNA and strains. The move comes after the company signed a similar agreement with WeedMD Inc. (TSX-V: WMD), another licensed producer in Canada.
Government Regulators
The cannabis industry is desperately seeking legitimacy as it moves from the illicit black market to a legalized market across a growing number of jurisdictions. Like any other consumer product, it’s only through the full faith and trust of government regulation that consumers will trust the product. The challenge for regulators is coming up with and implementing controls to ensure that products are tested and verified.
BLOCKStrain leverages immutable and secure blockchain technology, as well as proprietary track-and-trace software, to provide the validation and verification that governments require. Governments are choosing BLOCKStrain as the backbone of certification, verification, consumer reporting, and the monitoring of federally-regulated reporting. The technology is a leap forward in legitimizing the industry and ensuring compliance.
Looking Ahead
BLOCKStrain Technology Corp. (TSX-V: DNAX) (OTC: BKKSF) addresses multiple parts of the cannabis value chain, making it a cornerstone technology in compliance and quality control. Investors interested in ancillary parts of the cannabis industry may want to take a closer look at the company following its recent deal with WeedMD Inc. (TSX-V: WMD), where it rolled out the industry’s first cannabis strain validation program in Canada’s mature market.
The company’s stock also became easier to purchase in the United States after securing DTC eligibility in late February. With improved settlement for its shares, U.S. investors can easily participate in the company’s growth story via a wide range of brokers.
For more information, visit the company’s website at www.blockstrain.io.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Zenabis owns 660,000 square feet of high quality indoor facility space, as well as 2.1 million square feet of greenhouse space that will be dedicated to cannabis production once fully built-out.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
